相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prostate-Specific Antigen Kinetics Following 5α-Reductase Inhibitor Treatment May Be a Useful Indicator for Repeat Prostate Biopsy
Ji Eun Heo et al.
YONSEI MEDICAL JOURNAL (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Outcomes of Prostate Cancer Screening by 5α-Reductase Inhibitor Use
Teemu J. Murtola et al.
JOURNAL OF UROLOGY (2017)
5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic Hyperplasia
Lauren P. Wallner et al.
MAYO CLINIC PROCEEDINGS (2016)
5α-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men With Prostate Cancer
Laurent Azoulay et al.
JAMA ONCOLOGY (2015)
5a-Reductase Inhibitors and Risk of High-Grade or Lethal Prostate Cancer.
Mark A. Preston et al.
JAMA INTERNAL MEDICINE (2014)
Long-Term Survival of Participants in the Prostate Cancer Prevention Trial
Ian M. Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Treatment with finasteride and prostate cancer survival
Anders Kjellman et al.
SCANDINAVIAN JOURNAL OF UROLOGY (2013)
The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
Faris Azzouni et al.
ADVANCES IN UROLOGY (2012)
Associations of Benign Prostatic Hyperplasia With Prostate Cancer: The Debate Continues
Ryan P. Kopp et al.
EUROPEAN UROLOGY (2011)
Association of Clinical Benign Prostate Hyperplasia with Prostate Cancer Incidence and Mortality Revisited: A Nationwide Cohort Study of 3 009 258 Men
David D. Orsted et al.
EUROPEAN UROLOGY (2011)
Effect of Dutasteride on Prostate Biopsy Rates and the Diagnosis of Prostate Cancer in Men with Lower Urinary Tract Symptoms and Enlarged Prostates in the Combination of Avodart and Tamsulosin Trial
Claus G. Roehrborn et al.
EUROPEAN UROLOGY (2011)
5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review
Timothy J. Wilt et al.
BJU INTERNATIONAL (2010)
The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study
Claus G. Roehrborn et al.
EUROPEAN UROLOGY (2010)
Effect of Dutasteride on the Risk of Prostate Cancer.
Gerald L. Andriole et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Five-alpha-reductase Inhibitors for prostate cancer prevention
T. J. Wilt et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2008)
Finasteride and high-grade prostate cancer in the prostate cancer prevention trial
M. Scott Lucia et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection
Ian M. Thompson et al.
JOURNAL OF UROLOGY (2007)
Effect of finasteride on the sensitivity of PSA for detecting prostate cancer
Ian M. Thompson et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Evidence for a biopsy derived grade artifact among larger prostate glands
GS Kulkarni et al.
JOURNAL OF UROLOGY (2006)
Differential alterations in 5α-reductas type 1 and type 2 levels during development and progression of prostate cancer
LN Thomas et al.
PROSTATE (2005)
Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia
GL Andriole et al.
UROLOGY (2004)
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia
JD McConnell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The influence of finasteride on the development of prostate cancer
IM Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
